Cite
HARVARD Citation
Graham, D. et al. (n.d.). Rifabutin (RHB‐105) Based Triple Therapy forHelicobacter pylori (HP)Infection Eradication: Results of Pivotal Phase 3 Multi‐Center Study (ERADICATE Hp2). American journal of gastroenterology. p. . [Online].